JASVINDER SINGH to Humans
This is a "connection" page, showing publications JASVINDER SINGH has written about Humans.
Connection Strength
3.644
-
Patient Perspectives on a Decision Aid for Systemic Lupus Erythematosus: Insights and Future Considerations. J Rheumatol. 2024 Aug 01; 51(8):798-803.
Score: 0.019
-
Association between diabetes mellitus and total hip arthroplasty outcomes: an observational study using the US National Inpatient Sample. BMJ Open. 2024 Jul 22; 14(7):e085400.
Score: 0.019
-
Re: Roxana Ramos, Ethan Ferguson, Mahmoud Abou Zeinab, et al. Single-port Transvesical Robot-assisted Simple Prostatectomy: Surgical Technique and Clinical Outcomes. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.11.012. Eur Urol. 2024 Sep; 86(3):e73.
Score: 0.019
-
A narrative review of the comparative safety of disease-modifying anti-rheumatic drugs used for the treatment of rheumatoid arthritis. Expert Opin Drug Saf. 2024 Jun; 23(6):687-714.
Score: 0.019
-
Contraception Care Patterns for Adult Females With Juvenile Idiopathic Arthritis on Teratogens in the Rheumatology Informatics System for Effectiveness (RISE) Registry. J Rheumatol. 2024 May 01; 51(5):542-545.
Score: 0.018
-
How to Use Janus Kinase Inhibitors in the Treatment of Rheumatoid Arthritis? A Clinical Assessment of Risks and Benefits. Curr Rheumatol Rep. 2023 12; 25(12):295-306.
Score: 0.018
-
Hypothyroidism Impacts Clinical and Healthcare Utilization Outcomes After Primary Total Hip Arthroplasty. J Arthroplasty. 2024 Sep; 39(9S2):S279-S286.e3.
Score: 0.018
-
Ileal Interposition for Ureteral Reconstruction Following Treatment for Abdominopelvic Malignancy: Complications and Outcomes From a Comprehensive Cancer Center. Urology. 2024 01; 183:215-220.
Score: 0.018
-
2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective. J Arthroplasty. 2023 11; 38(11):2193-2201.
Score: 0.018
-
2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective. Arthritis Care Res (Hoboken). 2023 11; 75(11):2227-2238.
Score: 0.018
-
2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective. Arthritis Rheumatol. 2023 11; 75(11):1877-1888.
Score: 0.018
-
The Emerging Safety Profile of JAK Inhibitors in Rheumatic Diseases. BioDrugs. 2023 Sep; 37(5):625-635.
Score: 0.017
-
Making the current non-surgical treatments for knee osteoarthritis more effective: Solutions from a diverse patient group. Joint Bone Spine. 2023 05; 90(3):105535.
Score: 0.017
-
Clustering Patients With Gout Based on Comorbidities and Biomarkers: A Cross-Sectional Study. J Rheumatol. 2023 06; 50(6):817-826.
Score: 0.017
-
Association between the number of adopted implementation strategies and contextual determinants: a mixed-methods study. BMC Health Serv Res. 2022 Dec 13; 22(1):1518.
Score: 0.017
-
Novel genetic loci associated with osteoarthritis in multi-ancestry analyses in the Million Veteran Program and UK Biobank. Nat Genet. 2022 12; 54(12):1816-1826.
Score: 0.017
-
Artificial Urinary Sphincter Considerations in Men With Prior Inflatable Penile Prosthesis Placement. J Sex Med. 2022 10; 19(10):1495-1498.
Score: 0.016
-
Treatment Guidelines in Rheumatoid Arthritis. Rheum Dis Clin North Am. 2022 08; 48(3):679-689.
Score: 0.016
-
Identifying physician-perceived barriers to a pragmatic treatment trial in rheumatoid arthritis. Eur J Rheumatol. 2022 07; 9(3):132-138.
Score: 0.016
-
Epidemiology and Outcomes of Alcohol Use Hospitalizations in People With Gout, Rheumatoid Arthritis, Fibromyalgia, Osteoarthritis, or Low Back Pain: A National US Study. J Clin Rheumatol. 2022 03 01; 28(2):e375-e380.
Score: 0.016
-
Patient Empowerment Among Adults With Arthritis: The Case for Emotional Support. J Rheumatol. 2022 08; 49(8):948-955.
Score: 0.016
-
Telemedicine Use During the COVID-19 Pandemic by Resilient Rheumatology Providers: A National Veterans Affairs Follow-up Survey. J Rheumatol. 2022 04; 49(4):424-431.
Score: 0.016
-
Risks and Benefits of Janus Kinase Inhibitors in Rheumatoid Arthritis - Past, Present, and Future. N Engl J Med. 2022 01 27; 386(4):387-389.
Score: 0.016
-
Re: Marc Sbizzera, Nicolas Morel-Journal, Alain Ruffion, et al. Rectourethral Fistula Induced by Localised Prostate Cancer Treatment: Surgical and Functional Outcomes of Transperineal Repair with Gracilis Muscle Flap Interposition. Eur Urol. 2022;81:305-12. Eur Urol. 2022 03; 81(3):e66-e67.
Score: 0.016
-
Telemedicine Including Video-Based Visits in Rheumatology in COVID-19 Pandemic: Not Yet Ideal. J Clin Rheumatol. 2022 Jan 01; 28(1):e292-e293.
Score: 0.016
-
Bladder Endometrioma. Mayo Clin Proc. 2022 01; 97(1):182-183.
Score: 0.016
-
SToRytelliing to Improve Disease outcomes in Gout (STRIDE-GO) in African American veterans with gout: a trial study protocol. Trials. 2021 Dec 04; 22(1):879.
Score: 0.016
-
"I wish it had a place to go": a nominal group study of barriers to the effectiveness of non-surgical treatments for knee osteoarthritis inclusive of minority populations. Arthritis Res Ther. 2021 12 01; 23(1):291.
Score: 0.016
-
SToRytelling to Improve Disease outcomes in Gout (STRIDE-GO): a multicenter, randomized controlled trial in African American veterans with gout. BMC Med. 2021 11 09; 19(1):265.
Score: 0.016
-
Dual-energy computed tomography vs ultrasound, alone or combined, for the diagnosis of gout: a prospective study of accuracy. Rheumatology (Oxford). 2021 10 02; 60(10):4861-4867.
Score: 0.015
-
Comment on: Dual-energy computed tomography versus ultrasound, alone or combined, for the diagnosis of gout: a prospective study of accuracy: reply. Rheumatology (Oxford). 2021 10 02; 60(10):e372-e374.
Score: 0.015
-
Epidemiology of hospitalizations with cocaine use disorder: A 17-year U.S. national study. J Psychiatr Res. 2021 12; 144:32-36.
Score: 0.015
-
Cardiovascular safety of febuxostat. Lancet. 2021 09 11; 398(10304):955.
Score: 0.015
-
Epidemiology of hospitalizations with amphetamine use disorder: A 17-year U.S. national cross-sectional study. Asian J Psychiatr. 2021 11; 65:102849.
Score: 0.015
-
Epidemiology, Time Trends, and Outcomes of Serious Infections in Patients With Vasculitis: A Nineteen-Year National Study. Arthritis Care Res (Hoboken). 2021 10; 73(10):1544-1551.
Score: 0.015
-
Recent health-related quality of life, but not change, predicted mortality and healthcare utilization. J Clin Epidemiol. 2021 12; 140:13-21.
Score: 0.015
-
Time-trends in hospitalizations with cannabis use disorder: A 17-year U.S. national study. Subst Abus. 2022; 43(1):408-414.
Score: 0.015
-
Management of Rheumatic Diseases During the COVID-19 Pandemic: A National Veterans Affairs Survey of Rheumatologists. Arthritis Care Res (Hoboken). 2021 07; 73(7):998-1003.
Score: 0.015
-
Comment on: Cannabis use assessment and its impact on pain in rheumatologic diseases: a systematic review and meta-analysis. Rheumatology (Oxford). 2021 06 18; 60(6):e222-e224.
Score: 0.015
-
Letter to the editor: Cocaine use and cocaine use disorder: Revisiting epidemiology and clinical impact. J Psychiatr Res. 2021 11; 143:467-468.
Score: 0.015
-
Serious Infections in Patients With Gout in the US: A?National Study of Incidence, Time Trends, and Outcomes. Arthritis Care Res (Hoboken). 2021 06; 73(6):898-908.
Score: 0.015
-
Time trends in hospitalizations with anxiolytic, sedative, or hypnotic drug use disorder: a 17-year U.S. national study. J Addict Dis. 2022 Jan-Mar; 40(1):4-11.
Score: 0.015
-
Epidemiology of hospitalizations with hallucinogen use disorder: a 17-year U.S. National study. J Addict Dis. 2021 Oct-Dec; 39(4):545-549.
Score: 0.015
-
How do dietary interventions affect serum urate and gout? Nat Rev Rheumatol. 2021 04; 17(4):191-192.
Score: 0.015
-
Time-trends in cocaine, hallucinogen, amphetamine, and sedative/anxiolytic/hypnotic use disorder hospitalizations in rheumatic diseases: a national time-trends study. Clin Rheumatol. 2021 Jul; 40(7):3007-3014.
Score: 0.015
-
Hospitalized Infections in Lupus: A Nationwide Study of Types of Infections, Time Trends, Health Care Utilization, and In-Hospital Mortality. Arthritis Rheumatol. 2021 04; 73(4):617-630.
Score: 0.015
-
Factors associated with healthcare utilization and mortality in alcohol use disorder hospitalization. Drug Alcohol Depend. 2021 05 01; 222:108653.
Score: 0.015
-
Belimumab for systemic lupus erythematosus. Cochrane Database Syst Rev. 2021 02 25; 2:CD010668.
Score: 0.015
-
Time trends in in-hospital mortality reduction in vasculitis vs. non-vasculitis hospitalisations vary by patient sex and age. Joint Bone Spine. 2021 07; 88(4):105141.
Score: 0.015
-
In-hospital mortality reduction in systemic lupus erythematosus over 2 decades varied by patient sex and age. Clin Rheumatol. 2021 Mar; 40(3):1201-1203.
Score: 0.015
-
Infection versus cardiovascular disease as leading causes of hospitalisations and associated mortality in vasculitis in the U.S.: a national study. Clin Exp Rheumatol. 2021 Mar-Apr; 39 Suppl 129(2):56-61.
Score: 0.015
-
Declining in-hospital mortality gap between systemic lupus erythematosus (SLE) and non-SLE hospitalisations: a national study. Ann Rheum Dis. 2021 05; 80(5):672-675.
Score: 0.014
-
Time Trends in Opioid Use Disorder Hospitalizations in Gout, Rheumatoid Arthritis, Fibromyalgia, Osteoarthritis, and Low Back Pain. J Rheumatol. 2021 05; 48(5):775-784.
Score: 0.014
-
Shared decision-making in gout treatment: a national study of rheumatology provider opinion and practice. Clin Rheumatol. 2021 Feb; 40(2):693-700.
Score: 0.014
-
Serious infections in Sj?gren's syndrome patients: a national U.S. study. Clin Exp Rheumatol. 2020 Jul-Aug; 38 Suppl 126(4):47-52.
Score: 0.014
-
Trends in Hospitalizations for Alcohol Use Disorder in the US From 1998 to 2016. JAMA Netw Open. 2020 09 01; 3(9):e2016580.
Score: 0.014
-
Hospitalized Infections in People With Osteoarthritis: A National US Study. J Rheumatol. 2021 06; 48(6):933-939.
Score: 0.014
-
Sjogren's syndrome is associated with higher rate of non-home discharge after primary hip arthroplasty and higher transfusion rates after primary hip or knee arthroplasty: a U.S. cohort study. BMC Musculoskelet Disord. 2020 Jul 25; 21(1):492.
Score: 0.014
-
Pop a pill or give myself a shot? Patient perspectives of disease-modifying anti-rheumatic drug choice for rheumatoid arthritis. Joint Bone Spine. 2021 01; 88(1):105053.
Score: 0.014
-
Response to: 'Cutaneous adverse events with febuxostat after previous reactions to allopurinol: comment on the artcile by Singh and Clevland' by Quills et al. Ann Rheum Dis. 2022 07; 81(7):e125.
Score: 0.014
-
Serious infections in people with systemic sclerosis: a national US study. Arthritis Res Ther. 2020 06 29; 22(1):163.
Score: 0.014
-
Response to: 'Correspondence to "Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data' by Ma et al. Ann Rheum Dis. 2022 06; 81(6):e108.
Score: 0.014
-
Response to: 'Confunding by indication and ethnicity difference? Comment on 'Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data'' by Hsu et al. Ann Rheum Dis. 2022 07; 81(7):e123.
Score: 0.014
-
Patient Perceptions of Gout Management Goals: A Cross-sectional Internet Survey. J Clin Rheumatol. 2020 Jun; 26(4):129-133.
Score: 0.014
-
A Randomized Internet-Based Pilot Feasibility and Planning Study of Cherry Extract and Diet Modification in Gout. J Clin Rheumatol. 2020 Jun; 26(4):147-156.
Score: 0.014
-
Gout epidemiology and comorbidities. Semin Arthritis Rheum. 2020 06; 50(3S):S11-S16.
Score: 0.014
-
Freedom of speech and public interest, not allegiance, should underpin science advisement to government. S Afr Med J. 2020 May 26; 110(7):578-580.
Score: 0.014
-
Serious infections in people with polymyalgia rheumatica (PMR) or giant cell arteritis (GCA): a time-trend national US study. Clin Rheumatol. 2020 Nov; 39(11):3427-3438.
Score: 0.014
-
Spondyloarthritis is associated with higher healthcare utilization and complication rates after primary total knee or total hip arthroplasty. Clin Rheumatol. 2020 Aug; 39(8):2345-2353.
Score: 0.014
-
Important determinants of the patient choice between TNF- vs. non-TNF Biologic disease-modifying anti-rheumatic drugs (DMARDs) for active rheumatoid arthritis (RA). Joint Bone Spine. 2020 07; 87(4):307-313.
Score: 0.014
-
Acute kidney injury after primary total hip arthroplasty: a risk multiplier for complication, mortality, and healthcare utilization. Arthritis Res Ther. 2020 02 19; 22(1):31.
Score: 0.014
-
National U.S. time-trends in opioid use disorder hospitalizations and associated healthcare utilization and mortality. PLoS One. 2020; 15(2):e0229174.
Score: 0.014
-
Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data. Ann Rheum Dis. 2020 04; 79(4):529-535.
Score: 0.014
-
Polymyositis has minimal effect on primary total knee or hip arthroplasty outcomes. Clin Rheumatol. 2020 Mar; 39(3):823-830.
Score: 0.014
-
Validation of the Hip Disability and Osteoarthritis Outcome Score and Knee Injury and Osteoarthritis Outcome Score Pain and Function Subscales for Use in Total Hip Replacement and Total Knee Replacement Clinical Trials. J Arthroplasty. 2020 05; 35(5):1200-1207.e4.
Score: 0.014
-
Socioeconomic status and healthcare access are associated with healthcare utilization after knee arthroplasty: A U.S. national cohort study. Joint Bone Spine. 2020 Mar; 87(2):157-162.
Score: 0.014
-
Total knee arthroplasty outcomes in lupus: a study using the US National Inpatient Sample. Rheumatology (Oxford). 2019 12 01; 58(12):2130-2136.
Score: 0.014
-
When Has a Knee or Hip Replacement Failed? A Patient Perspective. J Rheumatol. 2021 03; 48(3):447-453.
Score: 0.014
-
Age, race, comorbidity, and insurance payer type are associated with outcomes after total ankle arthroplasty. Clin Rheumatol. 2020 Mar; 39(3):881-890.
Score: 0.014
-
Association of Early Postoperative Pain Trajectories With Longer-term Pain Outcome After Primary Total Knee Arthroplasty. JAMA Netw Open. 2019 11 01; 2(11):e1915105.
Score: 0.013
-
How Systemic Sclerosis Affects Healthcare Use and Complication Rates after Total Hip Arthroplasty. J Rheumatol. 2020 08 01; 47(8):1218-1223.
Score: 0.013
-
Are the days of missed or delayed diagnosis of gout over? Nat Rev Rheumatol. 2019 10; 15(10):578-580.
Score: 0.013
-
Tai Chi for rheumatoid arthritis. Cochrane Database Syst Rev. 2019 09 25; 9:CD004849.
Score: 0.013
-
Comparative effectiveness of allopurinol and febuxostat for the risk of atrial fibrillation in the elderly: a propensity-matched analysis of Medicare claims data. Eur Heart J. 2019 09 21; 40(36):3046-3054.
Score: 0.013
-
Systemic sclerosis is associated with knee arthroplasty outcomes: a National US study. Clin Rheumatol. 2020 Jan; 39(1):85-92.
Score: 0.013
-
Factors Influencing the Effectiveness of Allopurinol in Achieving and Sustaining Target Serum Urate in a US Veterans Affairs Gout Cohort. J Rheumatol. 2020 03; 47(3):449-460.
Score: 0.013
-
Filgotinib, a JAK1 Inhibitor, for Treatment-Resistant Rheumatoid Arthritis. JAMA. 2019 07 23; 322(4):309-311.
Score: 0.013
-
Factors influencing implementation of a computerized, individualized, culturally tailored lupus decision aid in lupus clinics: a qualitative semi-structured interview study. Clin Rheumatol. 2019 Oct; 38(10):2793-2801.
Score: 0.013
-
Cardiovascular Disease Risk in Older Adults and Elderly Patients with Rheumatoid Arthritis: What Role Can Disease-Modifying Antirheumatic Drugs Play in Cardiovascular Risk Reduction? Drugs Aging. 2019 06; 36(6):493-510.
Score: 0.013
-
Insurance Payer Type and Patient Income Are Associated with Outcomes after Total Shoulder Arthroplasty. J Rheumatol. 2020 04; 47(4):589-596.
Score: 0.013
-
Individualized decision aid for diverse women with lupus nephritis (IDEA-WON): A randomized controlled trial. PLoS Med. 2019 05; 16(5):e1002800.
Score: 0.013
-
Rates of Total Joint Replacement in the United States: Future Projections to 2020-2040 Using the National Inpatient Sample. J Rheumatol. 2019 09; 46(9):1134-1140.
Score: 0.013
-
Gout and chronic pain in older adults: a Medicare claims study. Clin Rheumatol. 2019 Jul; 38(7):1953-1960.
Score: 0.013
-
Gout is associated with a higher risk of chronic renal disease in older adults: a retrospective cohort study of U.S. Medicare population. BMC Nephrol. 2019 03 15; 20(1):93.
Score: 0.013
-
The risk of Sjogren's syndrome in the older adults with gout: A medicare claims study. Joint Bone Spine. 2019 Oct; 86(5):615-619.
Score: 0.013
-
Gout is associated with increased healthcare utilization after knee arthroplasty. Ann Rheum Dis. 2019 08; 78(8):1146-1148.
Score: 0.013
-
Challenges of Practicing Rheumatology in a Government Setting: A County Hospital and Veterans Affairs Hospital Perspective. Rheum Dis Clin North Am. 2019 02; 45(1):39-51.
Score: 0.013
-
Self-reported sleep quality and sleep disorders in people with physician-diagnosed gout: an Internet cross-sectional survey. Arthritis Res Ther. 2019 01 25; 21(1):36.
Score: 0.013
-
Gout and healthcare utilization and complications after hip arthroplasty: a cohort study using the US National Inpatient Sample (NIS). Clin Rheumatol. 2019 Apr; 38(4):1213-1216.
Score: 0.013
-
The Third Biennial 2018 OMERACT First-time Participant Program: A Qualitative and Quantitative Study. J Rheumatol. 2019 08; 46(8):1036-1040.
Score: 0.013
-
Gout and the risk of Parkinson's disease in older adults: a study of U.S. Medicare data. BMC Neurol. 2019 Jan 05; 19(1):4.
Score: 0.013
-
Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. Arthritis Rheumatol. 2019 01; 71(1):5-32.
Score: 0.013
-
Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. Arthritis Care Res (Hoboken). 2019 01; 71(1):2-29.
Score: 0.013
-
Gout and dementia in the elderly: a cohort study of Medicare claims. BMC Geriatr. 2018 11 14; 18(1):281.
Score: 0.013
-
Any sleep is a dream far away: a nominal group study assessing how gout affects sleep. Rheumatology (Oxford). 2018 11 01; 57(11):1925-1932.
Score: 0.013
-
Gout and the risk of incident depression in older adults. Psychiatry Res. 2018 12; 270:842-844.
Score: 0.013
-
Tapering Janus kinase inhibitors in rheumatoid arthritis with low disease activity or remission: reality or dream? Ann Rheum Dis. 2019 02; 78(2):153-154.
Score: 0.013
-
Gout and the Risk of Incident Obstructive Sleep Apnea in Adults 65 Years or Older: An Observational Study. J Clin Sleep Med. 2018 09 15; 14(9):1521-1527.
Score: 0.012
-
Gout and hearing impairment in the elderly: a retrospective cohort study using the US Medicare claims data. BMJ Open. 2018 08 20; 8(8):e022854.
Score: 0.012
-
Goals of gout treatment: a patient perspective. Clin Rheumatol. 2018 Sep; 37(9):2557-2566.
Score: 0.012
-
Comparative effectiveness of allopurinol versus febuxostat for preventing incident dementia in older adults: a propensity-matched analysis. Arthritis Res Ther. 2018 08 03; 20(1):167.
Score: 0.012
-
Gout and Hypothyroidism in the Elderly: an Observational Cohort Study Using U.S. Medicare Claims Data. J Gen Intern Med. 2018 08; 33(8):1229-1231.
Score: 0.012
-
Gout and the risk of age-related macular degeneration in the elderly. PLoS One. 2018; 13(7):e0199562.
Score: 0.012
-
Association of Gout With Uveitis in Older Individuals. JAMA Ophthalmol. 2018 07 01; 136(7):835-837.
Score: 0.012
-
The association of gout with incident giant cell arteritis in older adults. Joint Bone Spine. 2019 03; 86(2):219-224.
Score: 0.012
-
Gout and the risk of myocardial infarction in older adults: a study of Medicare recipients. Arthritis Res Ther. 2018 06 01; 20(1):109.
Score: 0.012
-
Medicaid or Medicare insurance payer status and household income are associated with outcomes after primary total hip arthroplasty. Clin Rheumatol. 2018 Sep; 37(9):2489-2496.
Score: 0.012
-
Allopurinol and the risk of incident peripheral arterial disease in the elderly: a US Medicare claims data study. Rheumatology (Oxford). 2018 03 01; 57(3):451-461.
Score: 0.012
-
Taking an Interdisciplinary Approach to Understanding and Improving Medication Adherence. J Gen Intern Med. 2018 02; 33(2):136-138.
Score: 0.012
-
Septic Arthritis in Emergency Departments in the US: A National Study of Health Care Utilization and Time Trends. Arthritis Care Res (Hoboken). 2018 02; 70(2):320-326.
Score: 0.012
-
Patients and surgeons provide endorsement of core domains for total joint replacement clinical trials. Arthritis Res Ther. 2017 Dec 06; 19(1):267.
Score: 0.012
-
Response to: 'Use of urate-lowering therapies is not associated with an increase in the risk of incident dementia in older adults' by Lee and Song. Ann Rheum Dis. 2018 10; 77(10):e74.
Score: 0.012
-
Is gout a risk equivalent to diabetes for stroke and myocardial infarction? A retrospective claims database study. Arthritis Res Ther. 2017 Oct 17; 19(1):228.
Score: 0.012
-
Patient Burden of Axial Spondyloarthritis. J Clin Rheumatol. 2017 Oct; 23(7):383-391.
Score: 0.012
-
Response to: 'A response to Singh. "Lesinurad combination therapy with allopurinol in gout: do CLEAR studies make the treatment of gout clearer?"' by Valiyil and Schechter. Ann Rheum Dis. 2018 07; 77(7):e42.
Score: 0.012
-
Gout Self-Management in African American Veterans: A Qualitative Exploration of Challenges and Solutions From Patients' Perspectives. Arthritis Care Res (Hoboken). 2017 11; 69(11):1724-1732.
Score: 0.012
-
Use of urate-lowering therapies is not associated with an increase in the risk of incident dementia in older adults. Ann Rheum Dis. 2018 08; 77(8):1243-1245.
Score: 0.012
-
Role of serum urate in neurocognitive function and dementia: new evidence contradicts old thinking. Ann Rheum Dis. 2018 03; 77(3):317-318.
Score: 0.012
-
Gout and comorbidity: a nominal group study of people with gout. Arthritis Res Ther. 2017 09 15; 19(1):204.
Score: 0.012
-
The burden of septic arthritis on the U.S. inpatient care: A national study. PLoS One. 2017; 12(8):e0182577.
Score: 0.012
-
Clinical Practice Guidelines: Incorporating Input From a Patient Panel. Arthritis Care Res (Hoboken). 2017 08; 69(8):1125-1130.
Score: 0.011
-
Management of Gout. Ann Intern Med. 2017 06 06; 166(11):855.
Score: 0.011
-
Comparative effectiveness of allopurinol versus febuxostat for preventing incident renal disease in older adults: an analysis of Medicare claims data. Ann Rheum Dis. 2017 Oct; 76(10):1669-1678.
Score: 0.011
-
Health care utilization in patients with gout: a prospective multicenter cohort study. BMC Musculoskelet Disord. 2017 05 31; 18(1):233.
Score: 0.011
-
Do outcomes reported in randomised controlled trials of joint replacement surgery fulfil the OMERACT 2.0 Filter? A review of the 2008 and 2013 literature. Syst Rev. 2017 05 30; 6(1):106.
Score: 0.011
-
The OMERACT First-time Participant Program: Fresh Eye from the New Guys. J Rheumatol. 2017 Oct; 44(10):1560-1563.
Score: 0.011
-
Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2017 05 08; 5:CD012657.
Score: 0.011
-
EULAR gout treatment guidelines by Richette et al.: uric acid and neurocognition. Ann Rheum Dis. 2018 04; 77(4):e20.
Score: 0.011
-
Allopurinol and the risk of ventricular arrhythmias in the elderly: a study using US Medicare data. BMC Med. 2017 03 22; 15(1):59.
Score: 0.011
-
Patient Endorsement of the Outcome Measures in Rheumatology (OMERACT) Total Joint Replacement (TJR) clinical trial draft core domain set. BMC Musculoskelet Disord. 2017 03 15; 18(1):111.
Score: 0.011
-
Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes. BMC Cardiovasc Disord. 2017 03 14; 17(1):76.
Score: 0.011
-
Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2017 03 10; 3:CD012591.
Score: 0.011
-
Evaluation and Management of the Patient With Suspected Inflammatory Spine Disease. Mayo Clin Proc. 2017 Apr; 92(4):555-564.
Score: 0.011
-
Individualized patient decision-aid for immunosuppressive drugs in women with lupus nephritis: study protocol of a randomized, controlled trial. BMC Musculoskelet Disord. 2017 01 31; 18(1):53.
Score: 0.011
-
Consensus on draft OMERACT core domains for clinical trials of Total Joint Replacement outcome by orthopaedic surgeons: a report from the International consensus on outcome measures in TJR trials (I-COMiTT) group. BMC Musculoskelet Disord. 2017 01 26; 18(1):45.
Score: 0.011
-
Achieving Consensus on Total Joint Replacement Trial Outcome Reporting Using the OMERACT Filter: Endorsement of the Final Core Domain Set for Total Hip and Total Knee Replacement Trials for Endstage Arthritis. J Rheumatol. 2017 Nov; 44(11):1723-1726.
Score: 0.011
-
Cytokine and neuropeptide levels are associated with pain relief in patients with chronically painful total knee arthroplasty: a pilot study. BMC Musculoskelet Disord. 2017 01 14; 18(1):17.
Score: 0.011
-
An underlying diagnosis of osteonecrosis of bone is associated with worse outcomes than osteoarthritis after total hip arthroplasty. BMC Musculoskelet Disord. 2017 01 09; 18(1):8.
Score: 0.011
-
Lesinurad combination therapy with allopurinol in gout: do CLEAR studies make the treatment of gout clearer? Ann Rheum Dis. 2017 05; 76(5):779-781.
Score: 0.011
-
Chasing crystals out of the body: will treat to serum urate target for gout help us get there? Ann Rheum Dis. 2017 04; 76(4):629-631.
Score: 0.011
-
Mapping Perceptions of Lupus Medication Decision-Making Facilitators: The Importance of Patient Context. Arthritis Care Res (Hoboken). 2016 12; 68(12):1787-1794.
Score: 0.011
-
Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA). Cochrane Database Syst Rev. 2016 11 17; 11:CD012437.
Score: 0.011
-
Increasing comorbidity is associated with worsening physical function and pain after primary total knee arthroplasty. BMC Musculoskelet Disord. 2016 10 07; 17(1):421.
Score: 0.011
-
Infections With Biologics in Rheumatoid Arthritis and Related Conditions: a Scoping Review of Serious or Hospitalized Infections in Observational Studies. Curr Rheumatol Rep. 2016 10; 18(10):61.
Score: 0.011
-
Comparative effectiveness of immunosuppressive drugs and corticosteroids for lupus nephritis: a systematic review and network meta-analysis. Syst Rev. 2016 09 13; 5(1):155.
Score: 0.011
-
Risk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: a systematic review and network meta-analysis. BMC Med. 2016 Sep 13; 14(1):137.
Score: 0.011
-
Allopurinol and the risk of stroke in older adults receiving medicare. BMC Neurol. 2016 Sep 07; 16(1):164.
Score: 0.011
-
Trends in revision hip and knee arthroplasty observations after implementation of a regional joint replacement registry. Can J Surg. 2016 Sep; 59(5):304-10.
Score: 0.011
-
Treatments for Lupus Nephritis: A Systematic Review and Network Metaanalysis. J Rheumatol. 2016 10; 43(10):1801-1815.
Score: 0.011
-
Emergency Department and Inpatient Healthcare utilization due to Hypertension. BMC Health Serv Res. 2016 07 26; 16:303.
Score: 0.011
-
Are allopurinol dose and duration of use nephroprotective in the elderly? A Medicare claims study of allopurinol use and incident renal failure. Ann Rheum Dis. 2017 Jan; 76(1):133-139.
Score: 0.011
-
Clinically important improvement thresholds for Harris Hip Score and its ability to predict revision risk after primary total hip arthroplasty. BMC Musculoskelet Disord. 2016 06 10; 17:256.
Score: 0.011
-
Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2016 May 13; (5):CD012183.
Score: 0.011
-
Allopurinol and the risk of atrial fibrillation in the elderly: a study using Medicare data. Ann Rheum Dis. 2017 Jan; 76(1):72-78.
Score: 0.011
-
Time Trends, Predictors, and Outcome of Emergency Department Use for Gout: A Nationwide US Study. J Rheumatol. 2016 08; 43(8):1581-8.
Score: 0.011
-
Cervical cancer risk with the use of tumour necrosis factor inhibitors in rheumatoid arthritis: to worry or not to worry? Ann Rheum Dis. 2016 07; 75(7):1265-7.
Score: 0.010
-
Gout-related inpatient utilization: a study of predictors of outcomes and time trends. Arthritis Res Ther. 2016 Mar 02; 18:57.
Score: 0.010
-
A cross-sectional internet-based patient survey of the management strategies for gout. BMC Complement Altern Med. 2016 Mar 01; 16:90.
Score: 0.010
-
Validation of the Mayo Hip Score: construct validity, reliability and responsiveness to change. BMC Musculoskelet Disord. 2016 Jan 19; 17:39.
Score: 0.010
-
Utilization due to chronic obstructive pulmonary disease and its predictors: a study using the U.S. National Emergency Department Sample (NEDS). Respir Res. 2016 Jan 06; 17:1.
Score: 0.010
-
Minorities with lupus nephritis and medications: a study of facilitators to medication decision-making. Arthritis Res Ther. 2015 Dec 17; 17:367.
Score: 0.010
-
A Real-World Study of Switching From Allopurinol to Febuxostat in a Health Plan Database. J Clin Rheumatol. 2015 Dec; 21(8):411-8.
Score: 0.010
-
Current tobacco use is associated with higher rates of implant revision and deep infection after total hip or knee arthroplasty: a prospective cohort study. BMC Med. 2015 Nov 19; 13:283.
Score: 0.010
-
Serum urate gene associations with incident gout, measured in the Framingham Heart Study, are modified by renal disease and not by body mass index. Rheumatol Int. 2016 Feb; 36(2):263-70.
Score: 0.010
-
Barriers to Medication Decision Making in Women with Lupus Nephritis: A Formative Study using Nominal Group Technique. J Rheumatol. 2015 Sep; 42(9):1616-23.
Score: 0.010
-
Investigational drugs for hyperuricemia. Expert Opin Investig Drugs. 2015; 24(8):1013-30.
Score: 0.010
-
An internet survey of common treatments used by patients with gout including cherry extract and juice and other dietary supplements. J Clin Rheumatol. 2015 Jun; 21(4):225-6.
Score: 0.010
-
Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort. Arthritis Res Ther. 2015 May 12; 17:120.
Score: 0.010
-
Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis. Lancet. 2015 Jul 18; 386(9990):258-65.
Score: 0.010
-
Rheumatoid arthritis is associated with higher ninety-day hospital readmission rates compared to osteoarthritis after hip or knee arthroplasty: a cohort study. Arthritis Care Res (Hoboken). 2015 May; 67(5):718-24.
Score: 0.010
-
Does hospital volume predict outcomes and complications after total shoulder arthroplasty in the US? Arthritis Care Res (Hoboken). 2015 May; 67(6):885-90.
Score: 0.010
-
Outcome Domains and Measures in Total Joint Replacement Clinical Trials: Can We Harmonize Them? An OMERACT Collaborative Initiative. J Rheumatol. 2015 Dec; 42(12):2496-502.
Score: 0.010
-
Are there racial disparities in utilization and outcomes after total elbow arthroplasty? Rheumatol Int. 2015 Sep; 35(9):1479-87.
Score: 0.010
-
Racial disparities in total ankle arthroplasty utilization and outcomes. Arthritis Res Ther. 2015 Mar 21; 17:70.
Score: 0.010
-
Does rural residence impact total ankle arthroplasty utilization and outcomes? Clin Rheumatol. 2016 Feb; 35(2):381-6.
Score: 0.010
-
Is the double contour sign specific for gout? Or only for crystal arthritis? J Rheumatol. 2015 Mar; 42(3):353-4.
Score: 0.010
-
Muscle inflammation susceptibility: a prognostic index of recovery potential after hip arthroplasty? Am J Physiol Endocrinol Metab. 2015 Apr 15; 308(8):E670-9.
Score: 0.010
-
Chondroitin for osteoarthritis. Cochrane Database Syst Rev. 2015 Jan 28; 1:CD005614.
Score: 0.010
-
Normative data and clinically significant effect sizes for single-item numerical linear analogue self-assessment (LASA) scales. Health Qual Life Outcomes. 2014 Dec 18; 12:187.
Score: 0.010
-
Increasing obesity and comorbidity in patients undergoing primary total hip arthroplasty in the U.S.: a 13-year study of time trends. BMC Musculoskelet Disord. 2014 Dec 17; 15:441.
Score: 0.010
-
Trends in and disparities for acute myocardial infarction: an analysis of Medicare claims data from 1992 to 2010. BMC Med. 2014 Oct 24; 12:190.
Score: 0.010
-
Sex differences in characteristics, utilization, and outcomes of patient undergoing total elbow arthroplasty: a study of the US nationwide inpatient sample. Clin Rheumatol. 2016 Mar; 35(3):723-31.
Score: 0.010
-
Time trends in the characteristics of patients undergoing primary total knee arthroplasty. Arthritis Care Res (Hoboken). 2014 Jun; 66(6):897-906.
Score: 0.009
-
Depression in primary TKA and higher medical comorbidities in revision TKA are associated with suboptimal subjective improvement in knee function. BMC Musculoskelet Disord. 2014 Apr 11; 15:127.
Score: 0.009
-
Challenges faced by patients in gout treatment: a qualitative study. J Clin Rheumatol. 2014 Apr; 20(3):172-4.
Score: 0.009
-
Research priorities in gout: the patient perspective. J Rheumatol. 2014 Mar; 41(3):615-6.
Score: 0.009
-
Editorial: Arthroplasty outcomes are improving, but why isn't my patient with rheumatoid arthritis doing as well? Arthritis Rheumatol. 2014 Feb; 66(2):250-3.
Score: 0.009
-
Predictors of pain medication use for arthroplasty pain after revision total knee arthroplasty. Rheumatology (Oxford). 2014 Oct; 53(10):1752-8.
Score: 0.009
-
Application of the OMERACT filter to measures of core outcome domains in recent clinical studies of acute gout. J Rheumatol. 2014 Mar; 41(3):574-80.
Score: 0.009
-
Reliability and clinically important improvement thresholds for osteoarthritis pain and function scales: a multicenter study. J Rheumatol. 2014 Mar; 41(3):509-15.
Score: 0.009
-
OMERACT 11: international consensus conference on outcome measures in rheumatology. J Rheumatol. 2014 Jan; 41(1):145-9.
Score: 0.009
-
OMERACT endorsement of measures of outcome for studies of acute gout. J Rheumatol. 2014 Mar; 41(3):569-73.
Score: 0.009
-
Better functional and similar pain outcomes in osteoarthritis compared to rheumatoid arthritis after primary total knee arthroplasty: a cohort study. Arthritis Care Res (Hoboken). 2013 Dec; 65(12):1936-41.
Score: 0.009
-
Diabetes: a risk factor for poor functional outcome after total knee arthroplasty. PLoS One. 2013; 8(11):e78991.
Score: 0.009
-
Patients with osteoarthritis and avascular necrosis have better functional outcomes and those with avascular necrosis worse pain outcomes compared to rheumatoid arthritis after primary hip arthroplasty: a cohort study. BMC Med. 2013 Sep 24; 11:210.
Score: 0.009
-
Racial disparities in knee and hip total joint arthroplasty: an 18-year analysis of national Medicare data. Ann Rheum Dis. 2014 Dec; 73(12):2107-15.
Score: 0.009
-
Operative diagnosis for revision total hip arthroplasty is associated with patient-reported outcomes (PROs). BMC Musculoskelet Disord. 2013 Jul 17; 14:210.
Score: 0.009
-
Medical comorbidity is associated with persistent index hip pain after total hip arthroplasty. Pain Med. 2013 Aug; 14(8):1222-9.
Score: 0.009
-
Ipsilateral lower extremity joint involvement increases the risk of poor pain and function outcomes after hip or knee arthroplasty. BMC Med. 2013 Jun 05; 11:144.
Score: 0.009
-
Cerebrovascular disease is associated with outcomes after total knee arthroplasty: a US total joint registry study. J Arthroplasty. 2014 Jan; 29(1):40-3.
Score: 0.009
-
Predictors of periprosthetic fracture after total knee replacement: an analysis of 21,723 cases. Acta Orthop. 2013 Apr; 84(2):170-7.
Score: 0.009
-
Income and patient-reported outcomes (PROs) after primary total knee arthroplasty. BMC Med. 2013 Mar 06; 11:62.
Score: 0.009
-
Use of biologics in a patient with rheumatoid arthritis refractory to methotrexate. CMAJ. 2013 Jun 11; 185(9):793-5.
Score: 0.009
-
Harms of TNF inhibitors in rheumatic diseases: a focused review of the literature. Immunotherapy. 2013 Mar; 5(3):265-99.
Score: 0.009
-
Crystal arthritis: Is HLAB genotyping the future of gout pharmacogenomics? Nat Rev Rheumatol. 2013 Apr; 9(4):200-2.
Score: 0.008
-
Patient-level clinically meaningful improvements in activities of daily living and pain after total hip arthroplasty: data from a large US institutional registry. Rheumatology (Oxford). 2013 Jun; 52(6):1109-18.
Score: 0.008
-
Racial and gender disparities among patients with gout. Curr Rheumatol Rep. 2013 Feb; 15(2):307.
Score: 0.008
-
Medical and psychological comorbidity predicts poor pain outcomes after total knee arthroplasty. Rheumatology (Oxford). 2013 May; 52(5):916-23.
Score: 0.008
-
Emerging therapies for gout. Expert Opin Emerg Drugs. 2012 Dec; 17(4):511-8.
Score: 0.008
-
Stem cells and other innovative intra-articular therapies for osteoarthritis: what does the future hold? BMC Med. 2012 May 02; 10:44.
Score: 0.008
-
Ninety-day mortality in patients undergoing elective total hip or total knee arthroplasty. J Arthroplasty. 2012 Sep; 27(8):1417-1422.e1.
Score: 0.008
-
Developing a provisional definition of flare in patients with established gout. Arthritis Rheum. 2012 May; 64(5):1508-17.
Score: 0.008
-
2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2012 May; 64(5):625-39.
Score: 0.008
-
Summary of AHRQ's comparative effectiveness review of drug therapy for rheumatoid arthritis (RA) in adults--an update. J Manag Care Pharm. 2012 May; 18(4 Supp C):S1-18.
Score: 0.008
-
Are gender, comorbidity, and obesity risk factors for postoperative periprosthetic fractures after primary total hip arthroplasty? J Arthroplasty. 2013 Jan; 28(1):126-31.e1-2.
Score: 0.008
-
Periprosthetic infections after total shoulder arthroplasty: a 33-year perspective. J Shoulder Elbow Surg. 2012 Nov; 21(11):1534-41.
Score: 0.008
-
Patient factors predict periprosthetic fractures after revision total hip arthroplasty. J Arthroplasty. 2012 Sep; 27(8):1507-12.
Score: 0.008
-
Can racial disparities in optimal gout treatment be reduced? Evidence from a randomized trial. BMC Med. 2012 Feb 09; 10:15.
Score: 0.008
-
A systematic review of validated methods for identifying orthopedic implant removal and revision using administrative data. Pharmacoepidemiol Drug Saf. 2012 Jan; 21 Suppl 1:265-73.
Score: 0.008
-
Periprosthetic infections after shoulder hemiarthroplasty. J Shoulder Elbow Surg. 2012 Oct; 21(10):1304-9.
Score: 0.008
-
Cardiopulmonary complications after primary shoulder arthroplasty: a cohort study. Semin Arthritis Rheum. 2012 Apr; 41(5):689-97.
Score: 0.008
-
Ninety day mortality and its predictors after primary shoulder arthroplasty: an analysis of 4,019 patients from 1976-2008. BMC Musculoskelet Disord. 2011 Oct 12; 12:231.
Score: 0.008
-
Risk factors for revision surgery after humeral head replacement: 1,431 shoulders over 3 decades. J Shoulder Elbow Surg. 2012 Aug; 21(8):1039-44.
Score: 0.008
-
Association of peptic ulcer disease and pulmonary disease with risk of periprosthetic fracture after primary total knee arthroplasty. Arthritis Care Res (Hoboken). 2011 Oct; 63(10):1471-6.
Score: 0.008
-
Smoking as a risk factor for short-term outcomes following primary total hip and total knee replacement in veterans. Arthritis Care Res (Hoboken). 2011 Oct; 63(10):1365-74.
Score: 0.008
-
Hospital volume and surgical outcomes after elective hip/knee arthroplasty: a risk-adjusted analysis of a large regional database. Arthritis Rheum. 2011 Aug; 63(8):2531-9.
Score: 0.008
-
Validation of pain and patient global scales in chronic gout: data from two randomised controlled trials. Ann Rheum Dis. 2011 Jul; 70(7):1277-81.
Score: 0.008
-
Patient-reported outcomes in chronic gout: a report from OMERACT 10. J Rheumatol. 2011 Jul; 38(7):1452-7.
Score: 0.008
-
Early postoperative mortality following joint arthroplasty: a systematic review. J Rheumatol. 2011 Jul; 38(7):1507-13.
Score: 0.008
-
Smoking and outcomes after knee and hip arthroplasty: a systematic review. J Rheumatol. 2011 Sep; 38(9):1824-34.
Score: 0.008
-
Use of biologics in rheumatoid arthritis: current and emerging paradigms of care. Clin Ther. 2011 Jun; 33(6):679-707.
Score: 0.008
-
Responsiveness differences in outcome instruments after revision hip arthroplasty: what are the implications? BMC Musculoskelet Disord. 2011 May 23; 12:107.
Score: 0.008
-
Risk factors for gout and prevention: a systematic review of the literature. Curr Opin Rheumatol. 2011 Mar; 23(2):192-202.
Score: 0.007
-
Adverse effects of biologics: a network meta-analysis and Cochrane overview. Cochrane Database Syst Rev. 2011 Feb 16; (2):CD008794.
Score: 0.007
-
Botulinum toxin for shoulder pain: a cochrane systematic review. J Rheumatol. 2011 Mar; 38(3):409-18.
Score: 0.007
-
Surgery for shoulder osteoarthritis: a Cochrane systematic review. J Rheumatol. 2011 Apr; 38(4):598-605.
Score: 0.007
-
Tocilizumab for rheumatoid arthritis: a Cochrane systematic review. J Rheumatol. 2011 Jan; 38(1):10-20.
Score: 0.007
-
Accuracy of VA databases for diagnoses of knee replacement and hip replacement. Osteoarthritis Cartilage. 2010 Dec; 18(12):1639-42.
Score: 0.007
-
Surgery for shoulder osteoarthritis. Cochrane Database Syst Rev. 2010 Oct 06; (10):CD008089.
Score: 0.007
-
Advances in gout: some answers, more questions. Arthritis Res Ther. 2010; 12(5):136.
Score: 0.007
-
Health care utilization in patients with gout. Semin Arthritis Rheum. 2011 Jun; 40(6):501-11.
Score: 0.007
-
Botulinum toxin for shoulder pain. Cochrane Database Syst Rev. 2010 Sep 08; (9):CD008271.
Score: 0.007
-
A national survey of Veterans Affairs rheumatologists for relevance of quality of care indicators for gout management. Arthritis Care Res (Hoboken). 2010 Sep; 62(9):1306-11.
Score: 0.007
-
Intraarticular botulinum toxin A for refractory painful total knee arthroplasty: a randomized controlled trial. J Rheumatol. 2010 Nov; 37(11):2377-86.
Score: 0.007
-
Tocilizumab for rheumatoid arthritis. Cochrane Database Syst Rev. 2010 Jul 07; (7):CD008331.
Score: 0.007
-
Golimumab for rheumatoid arthritis: a systematic review. J Rheumatol. 2010 Jun; 37(6):1096-104.
Score: 0.007
-
Pegloticase for chronic gout. Cochrane Database Syst Rev. 2010 Mar 17; (3):CD008335.
Score: 0.007
-
Challenges with health-related quality of life assessment in arthroplasty patients: problems and solutions. J Am Acad Orthop Surg. 2010 Feb; 18(2):72-82.
Score: 0.007
-
Golimumab for rheumatoid arthritis. Cochrane Database Syst Rev. 2010 Jan 20; (1):CD008341.
Score: 0.007
-
Abatacept for rheumatoid arthritis: a Cochrane systematic review. J Rheumatol. 2010 Feb; 37(2):234-45.
Score: 0.007
-
Newer biological agents in rheumatoid arthritis: impact on health-related quality of life and productivity. Drugs. 2010; 70(2):121-45.
Score: 0.007
-
Biologics for rheumatoid arthritis: an overview of Cochrane reviews. Sao Paulo Med J. 2010; 128(5):309-10.
Score: 0.007
-
Assessment of the methodologic quality of medical and surgical clinical trials in patients with arthroplasty. J Rheumatol. 2009 Dec; 36(12):2642-54.
Score: 0.007
-
A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview. CMAJ. 2009 Nov 24; 181(11):787-96.
Score: 0.007
-
Abatacept for rheumatoid arthritis. Cochrane Database Syst Rev. 2009 Oct 07; (4):CD007277.
Score: 0.007
-
Biologics for rheumatoid arthritis: an overview of Cochrane reviews. Cochrane Database Syst Rev. 2009 Oct 07; (4):CD007848.
Score: 0.007
-
Mobile and fixed-bearing (all-polyethylene tibial component) total knee arthroplasty designs. A prospective randomized trial. J Bone Joint Surg Am. 2009 Sep; 91(9):2104-12.
Score: 0.007
-
Trial sample size, but not trial quality, is associated with positive study outcome. J Clin Epidemiol. 2010 Feb; 63(2):154-62.
Score: 0.007
-
Discordance between self-report of physician diagnosis and administrative database diagnosis of arthritis and its predictors. J Rheumatol. 2009 Sep; 36(9):2000-8.
Score: 0.007
-
Higher comorbidity, poor functional status and higher health care utilization in veterans with prevalent total knee arthroplasty or total hip arthroplasty. Clin Rheumatol. 2009 Sep; 28(9):1025-33.
Score: 0.007
-
Effect of comorbidity on quality of life of male veterans with prevalent primary total knee arthroplasty. Clin Rheumatol. 2009 Sep; 28(9):1083-9.
Score: 0.007
-
Anakinra for rheumatoid arthritis: a systematic review. J Rheumatol. 2009 Jun; 36(6):1118-25.
Score: 0.007
-
Spondyloarthritis is associated with poor function and physical health-related quality of life. J Rheumatol. 2009 May; 36(5):1012-20.
Score: 0.006
-
Quality of life and quality of care for patients with gout. Curr Rheumatol Rep. 2009 Apr; 11(2):154-60.
Score: 0.006
-
Intra-articular botulinum toxin A for refractory shoulder pain: a randomized, double-blinded, placebo-controlled trial. Transl Res. 2009 May; 153(5):205-16.
Score: 0.006
-
Effect of resistance exercise on bone mineral density in premenopausal women. Joint Bone Spine. 2009 May; 76(3):273-80.
Score: 0.006
-
Health care utilization in patients with spondyloarthropathies. Rheumatology (Oxford). 2009 Mar; 48(3):272-6.
Score: 0.006
-
Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials. Am J Manag Care. 2008 Apr; 14(4):234-54.
Score: 0.006
-
Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans. Ann Rheum Dis. 2008 Sep; 67(9):1310-6.
Score: 0.006
-
Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials. Am J Manag Care. 2007 Dec; 13 Suppl 9:S237-51.
Score: 0.006
-
Effect of health-related quality of life on women and men's Veterans Affairs (VA) health care utilization and mortality. J Gen Intern Med. 2007 Sep; 22(9):1260-7.
Score: 0.006
-
Contributions of OMERACT to rheumatic disease research. Arthritis Rheum. 2007 Feb 15; 57(1):186.
Score: 0.006
-
Diphtheria toxoid loaded poly-(epsilon-caprolactone) nanoparticles as mucosal vaccine delivery systems. Methods. 2006 Feb; 38(2):96-105.
Score: 0.005
-
Health-related quality of life predicts future health care utilization and mortality in veterans with self-reported physician-diagnosed arthritis: the veterans arthritis quality of life study. Semin Arthritis Rheum. 2005 Apr; 34(5):755-65.
Score: 0.005
-
Health-related quality of life, functional impairment, and healthcare utilization by veterans: veterans' quality of life study. J Am Geriatr Soc. 2005 Jan; 53(1):108-13.
Score: 0.005
-
Quantitative analysis of immunohistologic features of very early rheumatoid synovitis in disease modifying antirheumatic drug- and corticosteroid-na?ve patients. J Rheumatol. 2004 Jul; 31(7):1281-5.
Score: 0.005
-
Weight Loss for Patients With Gout and Concomitant Obesity: A Proof-of-Concept Randomized Trial. Arthritis Rheumatol. 2024 May; 76(5):806-812.
Score: 0.005
-
Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials. Semin Arthritis Rheum. 2024 Apr; 65:152381.
Score: 0.005
-
OMERACT Core outcome measurement set for shared decision making in rheumatic and musculoskeletal conditions: a scoping review to identify candidate instruments. Semin Arthritis Rheum. 2024 Apr; 65:152344.
Score: 0.004
-
Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working Group. Semin Arthritis Rheum. 2023 12; 63:152288.
Score: 0.004
-
Hearing Loss Prevalence, Years Lived With Disability, and Hearing Aid Use in the United States From 1990 to 2019: Findings From the Global Burden of Disease Study. Ear Hear. 2024 Jan-Feb 01; 45(1):257-267.
Score: 0.004
-
Systemic treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials. J Allergy Clin Immunol. 2023 12; 152(6):1470-1492.
Score: 0.004
-
Talo-patello-scaphoid osteolysis, synovitis, and short fourth metacarpals in sisters: a new syndrome? Am J Med Genet A. 2003 Aug 30; 121A(2):118-25.
Score: 0.004
-
Outcome reporting in randomized trials in gout: A systematic scoping review from the OMERACT gout working group assessing the uptake of the core outcome set. Semin Arthritis Rheum. 2023 06; 60:152191.
Score: 0.004
-
Higher Pain Catastrophizing and Preoperative Pain is Associated with Increased Risk for Prolonged Postoperative Opioid Use. Pain Physician. 2023 03; 26(2):E73-E82.
Score: 0.004
-
Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000-2018. BMC Med. 2022 12 19; 20(1):488.
Score: 0.004
-
Management of Concomitant Inflammatory Bowel Disease or Uveitis in Patients with Psoriatic Arthritis: An Updated Review Informing the 2021 GRAPPA Treatment Recommendations. J Rheumatol. 2023 03; 50(3):438-450.
Score: 0.004
-
Muscle transcriptomic circuits linked to periarticular physiology in end-stage osteoarthritis. Physiol Genomics. 2022 12 01; 54(12):501-513.
Score: 0.004
-
A Framework for the Development of Living Practice Guidelines in Health Care. Ann Intern Med. 2022 08; 175(8):1154-1160.
Score: 0.004
-
Telemedicine in rheumatology care: A systematic review. Semin Arthritis Rheum. 2022 10; 56:152045.
Score: 0.004
-
Perioperative assessment of muscle inflammation susceptibility in patients with end-stage osteoarthritis. J Appl Physiol (1985). 2022 04 01; 132(4):984-994.
Score: 0.004
-
Racial Differences in XO (Xanthine Oxidase) and Mitochondrial DNA Damage-Associated Molecular Patterns in Resistant Hypertension. Hypertension. 2022 04; 79(4):775-784.
Score: 0.004
-
Serum urate as a proposed surrogate outcome measure in gout trials: From the OMERACT working group. Semin Arthritis Rheum. 2021 12; 51(6):1378-1385.
Score: 0.004
-
Benefit-risk assessment and reporting in clinical trials of chronic pain treatments: IMMPACT recommendations. Pain. 2022 06 01; 163(6):1006-1018.
Score: 0.004
-
Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey. RMD Open. 2021 09; 7(3).
Score: 0.004
-
Considerations and priorities for incorporating the patient perspective on remission in rheumatoid arthritis: An OMERACT 2020 special interest group report. Semin Arthritis Rheum. 2021 10; 51(5):1108-1112.
Score: 0.004
-
Healthcare is a Team Sport: Stress, Resilience, and Correlates of Well-Being Among Health System Employees in a Crisis. J Healthc Manag. 2021 Jul-Aug 01; 66(4):304-322.
Score: 0.004
-
Higher Serum Urate Levels Are Associated With an Increased Risk for Sudden Cardiac Death. J Rheumatol. 2021 11; 48(11):1745-1753.
Score: 0.004
-
Towards development of core domain sets for short term and long term studies of calcium pyrophosphate crystal deposition (CPPD) disease: A framework paper by the OMERACT CPPD working group. Semin Arthritis Rheum. 2021 08; 51(4):946-950.
Score: 0.004
-
2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Rheumatol. 2021 07; 73(7):1108-1123.
Score: 0.004
-
2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2021 07; 73(7):924-939.
Score: 0.004
-
Experience and impact of crystal pyrophosphate deposition (CPPD) from a patient and caregiver perspective: A qualitative exploration from the OMERACT CPPD working group. Semin Arthritis Rheum. 2021 06; 51(3):655-660.
Score: 0.004
-
OMERACT 2020: A virtual (R)evolution. Semin Arthritis Rheum. 2021 06; 51(3):588-592.
Score: 0.004
-
Endorsement of the OMERACT core domain set for shared decision making interventions in rheumatology trials: Results from a multi-stepped consensus-building approach. Semin Arthritis Rheum. 2021 06; 51(3):593-600.
Score: 0.004
-
OMERACT consensus-based operational definition of contextual factors in rheumatology clinical trials: A mixed methods study. Semin Arthritis Rheum. 2021 06; 51(3):601-606.
Score: 0.004
-
Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) common language definition of gout. RMD Open. 2021 04; 7(2).
Score: 0.004
-
Genetic correlations between traits associated with hyperuricemia, gout, and comorbidities. Eur J Hum Genet. 2021 09; 29(9):1438-1445.
Score: 0.004
-
Which factors predict discordance between a patient and physician on a gout flare? Rheumatology (Oxford). 2021 02 01; 60(2):773-779.
Score: 0.004
-
Outcome domains reported by patients, caregivers, healthcare professionals and stakeholders for calcium pyrophosphate deposition (CPPD): A content analysis based on semi-structured qualitative interviews from the OMERACT CPPD working group. Semin Arthritis Rheum. 2021 06; 51(3):650-654.
Score: 0.004
-
Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations. Pain. 2020 11; 161(11):2446-2461.
Score: 0.004
-
Estimating global injuries morbidity and mortality: methods and data used in the Global Burden of Disease 2017 study. Inj Prev. 2020 10; 26(Supp 1):i125-i153.
Score: 0.004
-
Patient, physiotherapist and surgeon endorsement of the core domain set for total hip and total knee replacement in Germany: a study protocol for an OMERACT initiative. BMJ Open. 2020 06 28; 10(6):e035207.
Score: 0.004
-
Outcome domains reported in calcium pyrophosphate deposition studies: A scoping review by the OMERACT CPPD working group. Semin Arthritis Rheum. 2020 08; 50(4):719-727.
Score: 0.004
-
2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Rheumatol. 2020 06; 72(6):879-895.
Score: 0.003
-
2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care Res (Hoboken). 2020 06; 72(6):744-760.
Score: 0.003
-
Flare Rate Thresholds for Patient Assessment of Disease Activity States in Gout. J Rheumatol. 2021 02; 48(2):293-298.
Score: 0.003
-
Global injury morbidity and mortality from 1990 to 2017: results from the Global Burden of Disease Study 2017. Inj Prev. 2020 10; 26(Supp 1):i96-i114.
Score: 0.003
-
Shoulder replacement surgery for osteoarthritis and rotator cuff tear arthropathy. Cochrane Database Syst Rev. 2020 04 21; 4:CD012879.
Score: 0.003
-
Gout is associated with an increased risk for incident heart failure among older adults: the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort study. Arthritis Res Ther. 2020 04 16; 22(1):86.
Score: 0.003
-
Burden of injury along the development spectrum: associations between the Socio-demographic Index and disability-adjusted life year estimates from the Global Burden of Disease Study 2017. Inj Prev. 2020 10; 26(Supp 1):i12-i26.
Score: 0.003
-
Scope of Outcomes in Trials and Observational Studies of Interventions Targeting Medication Adherence in Rheumatic Conditions: A Systematic Review. J Rheumatol. 2020 10 01; 47(10):1565-1574.
Score: 0.003
-
Severity of Hypertension Mediates the Association of Hyperuricemia With Stroke in the REGARDS Case Cohort Study. Hypertension. 2020 01; 75(1):246-256.
Score: 0.003
-
Mapping 123 million neonatal, infant and child deaths between 2000 and 2017. Nature. 2019 10; 574(7778):353-358.
Score: 0.003
-
Defining ranges for certainty ratings of diagnostic accuracy: a GRADE concept paper. J Clin Epidemiol. 2020 01; 117:138-148.
Score: 0.003
-
Pain Measurement in Rheumatic and Musculoskeletal Diseases: Where To Go from Here? Report from a Special Interest Group at OMERACT 2018. J Rheumatol. 2019 10; 46(10):1355-1359.
Score: 0.003
-
Core Domain Set Selection According to OMERACT Filter 2.1: The OMERACT Methodology. J Rheumatol. 2019 08; 46(8):1014-1020.
Score: 0.003
-
OMERACT Filter 2.1: Elaboration of the Conceptual Framework for Outcome Measurement in Health Intervention Studies. J Rheumatol. 2019 08; 46(8):1021-1027.
Score: 0.003
-
GRADE guidelines: 22. The GRADE approach for tests and strategies-from test accuracy to patient-important outcomes and recommendations. J Clin Epidemiol. 2019 07; 111:69-82.
Score: 0.003
-
Instrument Selection Using the OMERACT Filter 2.1: The OMERACT Methodology. J Rheumatol. 2019 08; 46(8):1028-1035.
Score: 0.003
-
OMERACT Development of a Core Domain Set of Outcomes for Shared Decision-making Interventions. J Rheumatol. 2019 10; 46(10):1409-1414.
Score: 0.003
-
Addressing Challenges in Developing a Core Domain Set in Adherence Interventions in Rheumatology: A Report from the OMERACT-Adherence Group. J Rheumatol. 2019 09; 46(9):1202-1206.
Score: 0.003
-
Identifying Provisional Generic Contextual Factor Domains for Clinical Trials in Rheumatology: Results from an OMERACT Initiative. J Rheumatol. 2019 09; 46(9):1159-1163.
Score: 0.003
-
Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials. J Rheumatol. 2019 08; 46(8):1053-1058.
Score: 0.003
-
Recommendations for the management of rheumatoid arthritis in the Eastern Mediterranean region: an adolopment of the 2015 American College of Rheumatology guidelines. Clin Rheumatol. 2018 Nov; 37(11):2947-2959.
Score: 0.003
-
Factors associated with the orthopaedic surgeon's decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1905 patients. Osteoarthritis Cartilage. 2018 10; 26(10):1311-1318.
Score: 0.003
-
Untangling the complex relationships between incident gout risk, serum urate, and its comorbidities. Arthritis Res Ther. 2018 05 03; 20(1):90.
Score: 0.003
-
Developing a core outcome domain set to assessing effectiveness of interdisciplinary multimodal pain therapy: the VAPAIN consensus statement on core outcome domains. Pain. 2018 04; 159(4):673-683.
Score: 0.003
-
Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol. Trials. 2018 Mar 27; 19(1):204.
Score: 0.003
-
Serum urate as surrogate endpoint for flares in people with gout: A systematic review and meta-regression analysis. Semin Arthritis Rheum. 2018 10; 48(2):293-301.
Score: 0.003
-
Brief Report: Validation of a Definition of Flare in Patients With Established Gout. Arthritis Rheumatol. 2018 03; 70(3):462-467.
Score: 0.003
-
Variability in the Reporting of Serum Urate and Flares in Gout Clinical Trials: Need for Minimum Reporting Requirements. J Rheumatol. 2018 03; 45(3):419-424.
Score: 0.003
-
Considering health equity when moving from evidence-based guideline recommendations to implementation: a case study from an upper-middle income country on the GRADE approach. Health Policy Plan. 2017 Dec 01; 32(10):1484-1490.
Score: 0.003
-
Trends in Joint Replacement Surgery in Patients with Rheumatoid Arthritis. J Rheumatol. 2018 02; 45(2):158-164.
Score: 0.003
-
Medication adherence among patients with gout: A systematic review and meta-analysis. Semin Arthritis Rheum. 2018 04; 47(5):689-702.
Score: 0.003
-
Adaptation of the 2015 American College of Rheumatology treatment guideline for rheumatoid arthritis for the Eastern Mediterranean Region: an exemplar of the GRADE Adolopment. Health Qual Life Outcomes. 2017 Sep 21; 15(1):183.
Score: 0.003
-
Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal studies. Ann Rheum Dis. 2017 Nov; 76(11):1870-1882.
Score: 0.003
-
GRADE equity guidelines 4: considering health equity in GRADE guideline development: evidence to decision process. J Clin Epidemiol. 2017 Oct; 90:84-91.
Score: 0.003
-
Validating Rheumatoid Arthritis Remission Using the Patients' Perspective: Results from a Special Interest Group at OMERACT 2016. J Rheumatol. 2017 Dec; 44(12):1889-1893.
Score: 0.003
-
Engaging Stakeholders and Promoting Uptake of OMERACT Core Outcome Instrument Sets. J Rheumatol. 2017 Oct; 44(10):1551-1559.
Score: 0.003
-
2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty. Arthritis Care Res (Hoboken). 2017 08; 69(8):1111-1124.
Score: 0.003
-
2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty. Arthritis Rheumatol. 2017 08; 69(8):1538-1551.
Score: 0.003
-
2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty. J Arthroplasty. 2017 09; 32(9):2628-2638.
Score: 0.003
-
Outcome Measures Used in Arthroplasty Trials: Systematic Review of the 2008 and 2013 Literature. J Rheumatol. 2017 08; 44(8):1277-1287.
Score: 0.003
-
GRADE equity guidelines 2: considering health equity in GRADE guideline development: equity extension of the guideline development checklist. J Clin Epidemiol. 2017 Oct; 90:68-75.
Score: 0.003
-
GRADE equity guidelines 1: considering health equity in GRADE guideline development: introduction and rationale. J Clin Epidemiol. 2017 Oct; 90:59-67.
Score: 0.003
-
GRADE equity guidelines 3: considering health equity in GRADE guideline development: rating the certainty of synthesized evidence. J Clin Epidemiol. 2017 Oct; 90:76-83.
Score: 0.003
-
Safety of Biologic and Nonbiologic Disease-modifying Antirheumatic Drug Therapy in Veterans with Rheumatoid Arthritis and Hepatitis C Virus Infection. J Rheumatol. 2017 05; 44(5):565-570.
Score: 0.003
-
Burden of musculoskeletal disorders in the Eastern Mediterranean Region, 1990-2013: findings from the Global Burden of Disease Study 2013. Ann Rheum Dis. 2017 Aug; 76(8):1365-1373.
Score: 0.003
-
Health Equity Considerations for Developing and Reporting Patient-reported Outcomes in Clinical Trials: A Report from the OMERACT Equity Special Interest Group. J Rheumatol. 2017 Nov; 44(11):1727-1733.
Score: 0.003
-
Low-dose SoluMatrix diclofenac in patients with osteoarthritis pain: impact on quality of life in a controlled trial. Clin Rheumatol. 2017 Jun; 36(6):1357-1367.
Score: 0.003
-
Using serum urate as a validated surrogate end point for flares in patients with gout: protocol for a systematic review and meta-regression analysis. BMJ Open. 2016 09 20; 6(9):e012026.
Score: 0.003
-
Defining the optimal biological monotherapy in rheumatoid arthritis: A systematic review and meta-analysis of randomised trials. Semin Arthritis Rheum. 2017 06; 46(6):699-708.
Score: 0.003
-
Assessment of physical function and participation in chronic pain clinical trials: IMMPACT/OMERACT recommendations. Pain. 2016 Sep; 157(9):1836-1850.
Score: 0.003
-
Renal dosing of allopurinol results in suboptimal gout care. Ann Rheum Dis. 2017 01; 76(1):e1.
Score: 0.003
-
Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises. Arthritis Care Res (Hoboken). 2016 05; 68(5):667-72.
Score: 0.003
-
GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health. J Clin Epidemiol. 2016 08; 76:89-98.
Score: 0.003
-
Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis. Ann Rheum Dis. 2016 Oct; 75(10):1813-8.
Score: 0.003
-
When Patients Write the Guidelines: Patient Panel Recommendations for the Treatment of Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2016 Jan; 68(1):26-35.
Score: 0.003
-
Do "Evidence-Based Recommendations" Need to Reveal the Evidence? Minimal Criteria Supporting an "Evidence Claim". J Rheumatol. 2015 Oct; 42(10):1737-9.
Score: 0.003
-
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015 Dec 05; 386(10010):2287-323.
Score: 0.003
-
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet. 2015 Nov 28; 386(10009):2145-91.
Score: 0.003
-
Toward Ensuring Health Equity: Readability and Cultural Equivalence of OMERACT Patient-reported Outcome Measures. J Rheumatol. 2015 Dec; 42(12):2448-59.
Score: 0.002
-
Validation of administrative codes for calcium pyrophosphate deposition: a Veterans Administration study. J Clin Rheumatol. 2015 Jun; 21(4):189-92.
Score: 0.002
-
Validity and sensitivity to change of three scales for the radiographic assessment of knee osteoarthritis using images from the Multicenter Osteoarthritis Study (MOST). Osteoarthritis Cartilage. 2015 Sep; 23(9):1491-8.
Score: 0.002
-
TNF-alpha inhibitors for ankylosing spondylitis. Cochrane Database Syst Rev. 2015 Apr 18; (4):CD005468.
Score: 0.002
-
Imaging as an Outcome Measure in Gout Studies: Report from the OMERACT Gout Working Group. J Rheumatol. 2015 Dec; 42(12):2460-4.
Score: 0.002
-
Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration. Ann Rheum Dis. 2016 Feb; 75(2):341-7.
Score: 0.002
-
Remembering the forgotten non-communicable diseases. BMC Med. 2014 Oct 22; 12:200.
Score: 0.002
-
A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis. BMJ. 2014 Sep 24; 349:g5630.
Score: 0.002
-
Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014 Sep 13; 384(9947):957-79.
Score: 0.002
-
Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014 Sep 13; 384(9947):980-1004.
Score: 0.002
-
Updating the OMERACT filter: discrimination and feasibility. J Rheumatol. 2014 May; 41(5):1005-10.
Score: 0.002
-
Updating the OMERACT filter: implications of filter 2.0 to select outcome instruments through assessment of "truth": content, face, and construct validity. J Rheumatol. 2014 May; 41(5):1000-4.
Score: 0.002
-
Updating the OMERACT filter: core areas as a basis for defining core outcome sets. J Rheumatol. 2014 May; 41(5):994-9.
Score: 0.002
-
Biological pathways, candidate genes, and molecular markers associated with quality-of-life domains: an update. Qual Life Res. 2014 Sep; 23(7):1997-2013.
Score: 0.002
-
How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0. J Rheumatol. 2014 May; 41(5):1025-30.
Score: 0.002
-
Updating the OMERACT filter: implications for imaging and soluble biomarkers. J Rheumatol. 2014 May; 41(5):1016-24.
Score: 0.002
-
Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0. J Clin Epidemiol. 2014 Jul; 67(7):745-53.
Score: 0.002
-
Comorbidities in patients with crystal diseases and hyperuricemia. Rheum Dis Clin North Am. 2014 May; 40(2):251-78.
Score: 0.002
-
Outcome measures in acute gout: a systematic literature review. J Rheumatol. 2014 Mar; 41(3):558-68.
Score: 0.002
-
Update of strategies to translate evidence from cochrane musculoskeletal group systematic reviews for use by various audiences. J Rheumatol. 2014 Feb; 41(2):206-15.
Score: 0.002
-
Updated method guidelines for cochrane musculoskeletal group systematic reviews and metaanalyses. J Rheumatol. 2014 Feb; 41(2):194-205.
Score: 0.002
-
Does clinically important change in function after knee replacement guarantee good absolute function? The multicenter osteoarthritis study. J Rheumatol. 2014 Jan; 41(1):60-4.
Score: 0.002
-
Including health equity considerations in development of instruments for rheumatology research: an introduction to a novel OMERACT paradigm. J Rheumatol. 2014 Jan; 41(1):150-2.
Score: 0.002
-
Participation following knee replacement: the MOST cohort study. Phys Ther. 2013 Nov; 93(11):1467-74.
Score: 0.002
-
The influence of the contralateral knee prior to knee arthroplasty on post-arthroplasty function: the multicenter osteoarthritis study. J Bone Joint Surg Am. 2013 Jun 05; 95(11):989-93.
Score: 0.002
-
The relation between cancer patient treatment decision-making roles and quality of life. Cancer. 2013 Jun 15; 119(12):2342-9.
Score: 0.002
-
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012 Dec 15; 380(9859):2163-96.
Score: 0.002
-
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012 Dec 15; 380(9859):2197-223.
Score: 0.002
-
Total knee arthroplasty volume, utilization, and outcomes among Medicare beneficiaries, 1991-2010. JAMA. 2012 Sep 26; 308(12):1227-36.
Score: 0.002
-
Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United States. Contemp Clin Trials. 2012 Nov; 33(6):1211-6.
Score: 0.002
-
Improved health-related quality of life and physical function in patients with refractory chronic gout following treatment with pegloticase: evidence from phase III randomized controlled trials. J Rheumatol. 2012 Jul; 39(7):1450-7.
Score: 0.002
-
Systematic review of tocilizumab for rheumatoid arthritis: a new biologic agent targeting the interleukin-6 receptor. Clin Ther. 2012 Apr; 34(4):788-802.e3.
Score: 0.002
-
The attributable risk of smoking on surgical complications. Ann Surg. 2011 Dec; 254(6):914-20.
Score: 0.002
-
OMERACT 10 Patient Perspective Virtual Campus: valuing health; measuring outcomes in rheumatoid arthritis fatigue, RA sleep, arthroplasty, and systemic sclerosis; and clinical significance of changes in health. J Rheumatol. 2011 Aug; 38(8):1728-34.
Score: 0.002
-
OARSI/OMERACT initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. An OMERACT 10 Special Interest Group. J Rheumatol. 2011 Aug; 38(8):1765-9.
Score: 0.002
-
Biologicals for rheumatoid arthritis. BMJ. 2011 Jul 28; 343:d4027.
Score: 0.002
-
Tophus measurement as an outcome measure for clinical trials of chronic gout: progress and research priorities. J Rheumatol. 2011 Jul; 38(7):1458-61.
Score: 0.002
-
Serum urate in chronic gout--will it be the first validated soluble biomarker in rheumatology? J Rheumatol. 2011 Jul; 38(7):1462-6.
Score: 0.002
-
Bringing it all together: a novel approach to the development of response criteria for chronic gout clinical trials. J Rheumatol. 2011 Jul; 38(7):1467-70.
Score: 0.002
-
Public health measures to control tuberculosis in low-income countries: ethics and human rights considerations. Int J Tuberc Lung Dis. 2011 Jun; 15 Suppl 2:19-24.
Score: 0.002
-
Minimally important differences of the gout impact scale in a randomized controlled trial. Rheumatology (Oxford). 2011 Jul; 50(7):1331-6.
Score: 0.002
-
Applying science in practice: the optimization of biological therapy in rheumatoid arthritis. Arthritis Res Ther. 2010; 12(6):220.
Score: 0.002
-
The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacement. Osteoarthritis Cartilage. 2011 Feb; 19(2):147-54.
Score: 0.002
-
Outcome domains for studies of acute and chronic gout. J Rheumatol. 2009 Oct; 36(10):2342-5.
Score: 0.002
-
Progress in measurement instruments for acute and chronic gout studies. J Rheumatol. 2009 Oct; 36(10):2346-55.
Score: 0.002
-
Variation in outcome measures in hip and knee arthroplasty clinical trials: a proposed approach to achieving consensus. J Rheumatol. 2009 Sep; 36(9):2050-6.
Score: 0.002
-
The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes. Twin Res Hum Genet. 2009 Jun; 12(3):301-11.
Score: 0.002
-
Intra-articular Botulinum Toxin Type A: a new approach to treat arthritis joint pain. Toxicon. 2009 Oct; 54(5):658-67.
Score: 0.002
-
Evaluation of an instrument assessing influence of Gout on health-related quality of life. J Rheumatol. 2008 Dec; 35(12):2406-14.
Score: 0.002
-
A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout. Ann Rheum Dis. 2008 Jun; 67(6):888-91.
Score: 0.001
-
Classification criteria in rheumatic diseases: a review of methodologic properties. Arthritis Rheum. 2007 Oct 15; 57(7):1119-33.
Score: 0.001
-
Use of breath carbon monoxide measurements to assess erythrocyte survival in subjects with chronic diseases. Am J Hematol. 2006 Jun; 81(6):432-8.
Score: 0.001
-
Oncogenic action of secreted phospholipase A2 in prostate cancer. Cancer Res. 2004 Oct 01; 64(19):6934-40.
Score: 0.001